Clinical strategies for acquired epidermal growth factor receptor tyrosine kinase inhibitor resistance in non-small-cell lung cancer patients

Overview of attention for article published in Oncotarget, August 2017

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
Among the highest-scoring outputs from this source (#31 of 14,344)
High Attention Score compared to outputs of the same age (99th percentile)
High Attention Score compared to outputs of the same age and source (99th percentile)

Mentioned by

news: 45 news outlets

reddit: 1 Redditor

Citations

dimensions_citation: 22 Dimensions

Readers on

mendeley: 21 Mendeley

Summary News Reddit Dimensions citations

So far, Dimensions has found 22 publications that cite this research output.

22

The most recent citing publications are shown below. View all 22 publications that cite this research output on Dimensions.

Recent Advances in Optically Controlled PROTAC

Article in Bioengineering (November 2023)

Genomic Landscape of Primary Resistance to Osimertinib Among Hispanic Patients with EGFR-Mutant Non-Small Cell Lung Cancer (NSCLC): Results of an Observational Longitudinal Cohort Study

Article in Targeted Oncology (April 2023)

PROTAC: targeted drug strategy. Principles and limitations

Article in Russian Chemical Bulletin (November 2022)